NASDAQ Health Care Index (IXHC) Companies by Market Cap
The NASDAQ Health Care Index (IXHC) tracks 976 constituent companies with a combined market cap of $2.51 Trillion, covering the largest publicly traded companies in USA. This ranking lists all IXHC index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$2.51 Trillion
Constituent Companies
976
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 151 |
89bio Inc
NASDAQ:ETNB |
% | $2.20 Billion | Healthcare | Biotechnology | $14.84 | +0.00% |
| 152 |
Zai Lab Ltd
NASDAQ:ZLAB |
% | $2.20 Billion | Healthcare | Biotechnology | $19.62 | -4.25% |
| 153 |
Dentsply Sirona Inc
NASDAQ:XRAY |
% | $2.19 Billion | Healthcare | Medical Instruments & Supplies | $12.78 | +4.24% |
| 154 |
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX |
% | $2.18 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $9.91 | -5.17% |
| 155 |
Ocular Therapeutix Inc
NASDAQ:OCUL |
% | $2.16 Billion | Healthcare | Biotechnology | $9.88 | -3.14% |
| 156 |
Avadel Pharmaceuticals PLC
NASDAQ:AVDL |
% | $2.12 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $21.64 | +0.05% |
| 157 |
Establishment Labs Holdings Inc
NASDAQ:ESTA |
% | $2.10 Billion | Healthcare | Medical Devices | $87.90 | -0.15% |
| 158 |
Axogen Inc
NASDAQ:AXGN |
% | $2.10 Billion | Healthcare | Medical Devices | $39.49 | -2.69% |
| 159 |
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH |
% | $2.05 Billion | Healthcare | Biotechnology | $16.03 | +1.58% |
| 160 |
Neogen Corporation
NASDAQ:NEOG |
% | $2.02 Billion | Healthcare | Diagnostics & Research | $9.65 | +0.31% |
| 161 |
Surgery Partners Inc
NASDAQ:SGRY |
% | $2.00 Billion | Healthcare | Medical Care Facilities | $15.98 | -2.56% |
| 162 |
Sarepta Therapeutics Inc
NASDAQ:SRPT |
% | $1.99 Billion | Healthcare | Biotechnology | $18.82 | -0.69% |
| 163 |
Nanobiotix
NASDAQ:NBTX |
% | $1.97 Billion | Healthcare | Biotechnology | $39.15 | -2.30% |
| 164 |
Rapport Therapeutics, Inc. Common Stock
NASDAQ:RAPP |
% | $1.94 Billion | Healthcare | Biotechnology | $40.59 | -2.78% |
| 165 |
AnaptysBio Inc
NASDAQ:ANAB |
% | $1.93 Billion | Healthcare | Biotechnology | $69.81 | +5.15% |
| 166 |
Nurix Therapeutics Inc
NASDAQ:NRIX |
% | $1.93 Billion | Healthcare | Biotechnology | $22.71 | -1.52% |
| 167 |
Mesoblast Ltd
NASDAQ:MESO |
% | $1.92 Billion | Healthcare | Biotechnology | $16.22 | +5.05% |
| 168 |
ADMA Biologics Inc
NASDAQ:ADMA |
% | $1.90 Billion | Healthcare | Biotechnology | $8.97 | -1.21% |
| 169 |
Syndax Pharmaceuticals Inc
NASDAQ:SNDX |
% | $1.89 Billion | Healthcare | Biotechnology | $22.89 | -3.05% |
| 170 |
Galapagos NV ADR
NASDAQ:GLPG |
% | $1.89 Billion | Healthcare | Biotechnology | $28.68 | -1.58% |
| 171 |
Omnicell Inc
NASDAQ:OMCL |
% | $1.88 Billion | Healthcare | Health Information Services | $46.68 | +3.92% |
| 172 |
Harmony Biosciences Holdings
NASDAQ:HRMY |
% | $1.86 Billion | Healthcare | Biotechnology | $35.54 | -3.53% |
| 173 |
Novocure Ltd
NASDAQ:NVCR |
% | $1.86 Billion | Healthcare | Medical Devices | $16.09 | -1.29% |
| 174 |
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX |
% | $1.85 Billion | Healthcare | Biotechnology | $28.15 | -2.63% |
| 175 |
Stoke Therapeutics Inc
NASDAQ:STOK |
% | $1.83 Billion | Healthcare | Biotechnology | $29.46 | -6.12% |
| 176 |
UFP Technologies Inc
NASDAQ:UFPT |
% | $1.83 Billion | Healthcare | Medical Devices | $237.25 | +0.14% |
| 177 |
Pharvaris BV
NASDAQ:PHVS |
% | $1.82 Billion | Healthcare | Biotechnology | $35.07 | +0.00% |
| 178 |
ANI Pharmaceuticals Inc
NASDAQ:ANIP |
% | $1.80 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $81.08 | -1.21% |
| 179 |
Zymeworks Inc. Common Stock
NASDAQ:ZYME |
% | $1.79 Billion | Healthcare | Biotechnology | $24.94 | -3.63% |
| 180 |
Dynavax Technologies Corporation
NASDAQ:DVAX |
% | $1.76 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $15.50 | +0.00% |
| 181 |
Zenas BioPharma, Inc. Common Stock
NASDAQ:ZBIO |
% | $1.76 Billion | Healthcare | Biotechnology | $27.88 | -2.99% |
| 182 |
MBX Biosciences, Inc. Common Stock
NASDAQ:MBX |
% | $1.76 Billion | Healthcare | Biotechnology | $60.04 | -1.65% |
| 183 |
Tyra Biosciences Inc
NASDAQ:TYRA |
% | $1.76 Billion | Healthcare | Biotechnology | $32.67 | -0.24% |
| 184 |
Palvella Therapeutics, Inc
NASDAQ:PVLA |
% | $1.75 Billion | Healthcare | Biotechnology | $146.03 | +0.88% |
| 185 |
Vericel Corp Ord
NASDAQ:VCEL |
% | $1.73 Billion | Healthcare | Biotechnology | $47.49 | +1.04% |
| 186 |
Recursion Pharmaceuticals Inc
NASDAQ:RXRX |
% | $1.73 Billion | Healthcare | Biotechnology | $3.30 | -7.30% |
| 187 |
Viridian Therapeutics Inc
NASDAQ:VRDN |
% | $1.71 Billion | Healthcare | Biotechnology | $18.99 | -3.80% |
| 188 |
Agios Pharm
NASDAQ:AGIO |
% | $1.71 Billion | Healthcare | Biotechnology | $40.55 | -1.65% |
| 189 |
Addus HomeCare Corporation
NASDAQ:ADUS |
% | $1.69 Billion | Healthcare | Medical Care Facilities | $108.86 | +0.60% |
| 190 |
RAPT Therapeutics Inc
NASDAQ:RAPT |
% | $1.68 Billion | Healthcare | Biotechnology | $58.01 | +0.00% |
| 191 |
Sionna Therapeutics, Inc. Common Stock
NASDAQ:SION |
% | $1.66 Billion | Healthcare | Biotechnology | $43.95 | -2.96% |
| 192 |
Innoviva Inc
NASDAQ:INVA |
% | $1.66 Billion | Healthcare | Biotechnology | $22.21 | -0.13% |
| 193 |
Immunocore Holdings Ltd
NASDAQ:IMCR |
% | $1.64 Billion | Healthcare | Biotechnology | $32.49 | +1.69% |
| 194 |
Clover Health Investments Corp
NASDAQ:CLOV |
% | $1.64 Billion | Healthcare | Healthcare Plans | $4.57 | +2.93% |
| 195 |
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX |
% | $1.64 Billion | Healthcare | Biotechnology | $17.41 | -2.03% |
| 196 |
Monte Rosa Therapeutics Inc
NASDAQ:GLUE |
% | $1.64 Billion | Healthcare | Biotechnology | $21.98 | -4.60% |
| 197 |
Maze Therapeutics, Inc. Common Stock
NASDAQ:MAZE |
% | $1.61 Billion | Healthcare | Biotechnology | $29.18 | -4.55% |
| 198 |
Abcellera Biologics Inc
NASDAQ:ABCL |
% | $1.61 Billion | Healthcare | Biotechnology | $6.52 | -4.12% |
| 199 |
Oruka Therapeutics, Inc.
NASDAQ:ORKA |
% | $1.56 Billion | Healthcare | Biotechnology | $84.56 | -2.57% |
| 200 |
ArriVent BioPharma, Inc. Common Stock
NASDAQ:AVBP |
% | $1.56 Billion | Healthcare | Biotechnology | $33.64 | -0.15% |
Complete list of all companies in the IXHC index ranked by market capitalization. Track index constituent performance and market values. View all indices